Hester Biosciences Ltd Share analysis
Excluding Excise Duty and Other Income, represents Net Revenue
Hester Biosciences Ltd revenue growth forecast
Expected growth rate Q1, FY2023:0.94%
Forecast
Actual
Including amortisation and stock based compensations
Hester Biosciences Ltd EPS growth forecast
EPS estimate Q1, FY2023:13.74%
Forecast
Actual
Source: S&P Global Market Intelligence
Hester Biosciences Ltd Performance
Day's Low
Day's High
₹2,368Day's Price Range₹2,439.0552 Week's Low
52 Week's High
₹1,292.8552-Week Price Range₹3,379
| Returns % | |
| 1 Month Return | + 1.01 % |
| 3 Month Return | -2.01 % |
| 1 Year Return | + 64.24 % |
| Market Stats | |
| Previous Close | ₹2,406.05 |
| Open | ₹2,439.05 |
| Volume | 2,031.00 |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹2,066.62Cr |
Hester Biosciences Ltd Key Statistics
| P/E Ratio | 77.84 |
| PEG Ratio | -28.41 |
| Market Cap | ₹2,066.62 Cr |
| P/B Ratio | 3.78 |
| EPS | 24.88 |
| Dividend Yield | 0.43 |
| Sector | Pharmaceuticals |
| ROE | 8.98 |
Hester Biosciences Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹2,066.62 Cr | 12.92% | 0.69 | ₹21 Cr | ₹304 Cr | |
| NA | ₹435.76 Cr | 272.24% | 0.54 | ₹28 Cr | ₹601 Cr | |
| NA | ₹15.41 Cr | 278.33% | 0.50 | NA | NA | |
| BUY | ₹23,100.09 Cr | 3.59% | 0.52 | NA | NA | |
| NA | ₹706.49 Cr | -0.07% | 0.57 | ₹9 Cr | ₹179 Cr |
About Hester Biosciences Ltd
Share Price: ₹2371.65 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹2,066.62Cr as of today
Revenue: ₹83.69Cr as on September 2024 (Q3 24)
Net Profit: ₹8.39Cr as on September 2024 (Q3 24)
Listing date: 13 Mar, 2015
| Organisation | Hester Biosciences Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Hester Biosciences Ltd
Hester Bio Reports Strong Q3 Growth in Sales - 29 Oct, 2024
Hester Biosciences Ltd announced consolidated net sales of Rs 83.69 crore for September 2024, an 18.79% increase YoY. Net profit surged 100.66% to Rs 8.20 crore, reflecting strong financial performance.Hester Biosciences Reports Strong Q2 FY25 Earnings - 28 Oct, 2024
Hester Biosciences announced impressive Q2 FY25 results, with revenue up 18.8% YoY and PAT surging 107.4%. The stock saw significant gains, reflecting investor confidence.
Insights on Hester Biosciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 4 quarters, 3.98 Cr → 8.2 Cr (in ₹), with an average increase of 21.4% per quarter
- POSITIVE IMPACT
Price Rise
In the last 3 years, HESTERBIO stock has moved up by 1.3%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.52% to 0.61% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 69.18 Cr → 86.49 Cr (in ₹), with an average increase of 6.9% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, HESTERBIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 134.4%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 53.73% of holdings in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 45.74% to 45.64% in Sep 2024 quarter
Hester Biosciences Ltd Financials
Index Inclusions
Hester Biosciences Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 53.73% | 0.00 | |
| Foreign Institutions | 0.61% | 16.15 | |
| Mutual Funds | 0% | 116.67 | |
| Retail Investors | 45.64% | ||
| Others | 0.02% | 0.00 |
Hester Biosciences Ltd Key Indicators
Hester Biosciences Ltd Valuation
Hester Biosciences Ltd in the last 5 years
Lowest (19.52x)
March 23, 2020
Industry (56.23x)
December 19, 2024
Today (77.84x)
December 19, 2024
Highest (124.52x)
July 26, 2024
Hester Biosciences Ltd Earnings and Dividends
Hester Biosciences Ltd Earnings Results
Hester Biosciences Ltd’s net profit jumped 100.49% since last year same period to ₹8.20Cr in the Q2 2024-2025. On a quarterly growth basis, Hester Biosciences Ltd has generated 29.34% jump in its net profits since last 3-months.
Read More about Earnings ResultsHester Biosciences Ltd Dividends May,2024
In the quarter ending March 2024, Hester Biosciences Ltd has declared dividend of ₹6 - translating a dividend yield of 0.59%.
Read More about Dividends
Hester Biosciences Ltd Technicals Summary
Bearish
Neutral
Bullish
Hester Biosciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Hester Biosciences Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Hester Biosciences Ltd shares.
Hester Biosciences Ltd (HESTERBIO) share price today is ₹2371.65
Hester Biosciences Ltd is listed on NSE
Hester Biosciences Ltd is listed on BSE
- Today’s highest price of Hester Biosciences Ltd is ₹2439.05.
- Today’s lowest price of Hester Biosciences Ltd is ₹2368.
PE Ratio of Hester Biosciences Ltd is 77.84
PE ratio = Hester Biosciences Ltd Market price per share / Hester Biosciences Ltd Earnings per share
Today’s traded volume of Hester Biosciences Ltd(HESTERBIO) is 2,031.00.
Today’s market capitalisation of Hester Biosciences Ltd(HESTERBIO) is ₹2066.62Cr.
| Hester Biosciences Ltd(HESTERBIO | Price |
|---|---|
52 Week High | ₹3379 |
52 Week Low | ₹1292.85 |
Hester Biosciences Ltd(HESTERBIO) share price is ₹2371.65. It is down -29.81% from its 52 Week High price of ₹3379
Hester Biosciences Ltd(HESTERBIO) share price is ₹2371.65. It is up 83.44% from its 52 Week Low price of ₹1292.85
| Hester Biosciences Ltd(HESTERBIO | Returns |
|---|---|
1 Day Returns | -34.4% |
1 Month Returns | 1.01% |
3 Month Returns | -2.01% |
1 Year Returns | 64.24% |